Published in Drug Des Devel Ther on May 12, 2014
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
The B7-CD28 superfamily. Nat Rev Immunol (2002) 7.24
LPS/TLR4 signal transduction pathway. Cytokine (2008) 6.60
IL-10: the master regulator of immunity to infection. J Immunol (2008) 6.11
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (1993) 4.45
Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Adhesion molecules and atherosclerosis. Atherosclerosis (2003) 3.68
T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol (2007) 3.65
Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation (2002) 3.60
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity (2009) 3.51
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A (2008) 3.40
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol (2002) 3.24
Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect (2002) 2.90
Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol (2000) 2.66
Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol (2004) 2.59
NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem (2006) 2.29
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol (1995) 2.28
Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke (2006) 2.24
Adaptive immunity and atherosclerosis. Clin Immunol (2009) 2.08
Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol (2009) 2.03
Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res (2006) 1.77
Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis (1996) 1.74
Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol (2006) 1.55
Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol (2002) 1.48
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47
Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol (2006) 1.34
Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol (1998) 1.34
T-cell costimulation and coinhibition in atherosclerosis. Circ Res (2008) 1.32
B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation (2004) 1.30
Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol (1996) 1.25
Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res (2005) 1.17
CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ Res (2009) 1.13
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One (2010) 1.06
Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis (1997) 1.00
Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J Immunol (2005) 0.97
Flagellin and lipopolysaccharide up-regulation of IL-6 and CXCLi2 gene expression in chicken heterophils is mediated by ERK1/2-dependent activation of AP-1 and NF-kappaB signaling pathways. Innate Immun (2008) 0.96
CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation. J Immunol (2000) 0.90
Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80. J Immunol (1998) 0.87
A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases. Arterioscler Thromb Vasc Biol (2007) 0.86
Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology (1997) 0.82
Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys. Clin Exp Immunol (2009) 0.79
Enhanced B7-2 gene expression by interferon-gamma in human monocytic cells is controlled through transcriptional and posttranscriptional mechanisms. Blood (1999) 0.79
The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. J Immunol (1996) 0.77
The tolls and dangers of atherosclerotic disease. Curr Pharm Biotechnol (2012) 0.77